Clifford Swan Investment Counsel’s Sanofi SNY Stock Holding History

Clifford Swan Investment Counsel’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,000	Closed	-$411K	–	322
2022 Q1	$411K	Hold	8,000	–	–	0.02%	248
2021 Q4	$401K	Hold	8,000	–	–	0.01%	255
2021 Q3	$410K	Hold	8,000	–	–	0.02%	252
2021 Q2	$399K	Hold	8,000	–	–	0.02%	246
2021 Q1	$396K	Sell	8,000 -149	-2%	-$7.16K	0.02%	249
2020 Q4	$396K	Hold	8,149	–	–	0.02%	242
2020 Q3	$409K	Buy	8,149 +149	+2%	+$7.67K	0.02%	226
2020 Q2	$408K	Hold	8,000	–	–	0.02%	225
2020 Q1	$350K	Hold	8,000	–	–	0.02%	222
2019 Q4	$402K	Hold	8,000	–	–	0.02%	231
2019 Q3	$371K	Hold	8,000	–	–	0.02%	231
2019 Q2	$346K	Hold	8,000	–	–	0.02%	237
2019 Q1	$354K	Sell	8,000 -540	-6%	-$23.1K	0.02%	235
2018 Q4	$371K	Hold	8,540	–	–	0.02%	226
2018 Q3	$381K	Hold	8,540	–	–	0.02%	234
2018 Q2	$342K	Hold	8,540	–	–	0.02%	245
2018 Q1	$342K	Hold	8,540	–	–	0.02%	246
2017 Q4	$367K	Buy	+8,540	New	+$394K	0.02%	235

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Clifford Swan Investment Counsel's SNY Position: Q2 2022 in Review

Clifford Swan Investment Counsel sold out of Sanofi (SNY) in Q2 2022, closing a stake of 8,000 shares — an estimated $411K sold.

Clifford Swan Investment Counsel first reported a position in SNY in Q4 2017 and held it in 18 quarters. The position peaked at $411K in Q1 2022. 656 funds tracked by Wall St. Rank hold SNY as of Q2 2022.

Clifford Swan Investment Counsel reported no remaining Sanofi position as of Q2 2022 after selling out during the quarter.
Clifford Swan Investment Counsel sold 8,000 Sanofi shares in Q2 2022, an estimated $411K.
Clifford Swan Investment Counsel first reported a position in Sanofi in Q4 2017 and held it in 18 quarters.
Clifford Swan Investment Counsel's Sanofi position peaked at $411K in Q1 2022.
656 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.

Based on Clifford Swan Investment Counsel's 13F filing for Q2 2022, filed 4 Aug 2022.